SUSAN KREPPEL: Open Payments
NPI 1376748640 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 45 payments from 15 companies in 2025. Trend: 2023 $17,735 · 2024 $15,552 · 2025 $701
Food & beverage: $691Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $141 |
| ABBVIE INC. | 5 | $99 |
| Lilly USA, LLC | 2 | $36 |
| QOL Medical, LLC | 1 | $35 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $22 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
Products named: TREMFYA, ENTYVIO, LINZESS, SKYRIZI, Sucraid, REZDIFFRA, REBYOTA, ZEPBOUND.
Industry payments across NY — which companies pay providers there.
